Rifampin
Rifampin for Injection, USP
Approved
Approval ID
8be91604-d7cd-4f2b-997d-e3364e4092e5
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 5, 2024
Manufacturers
FDA
Mylan Institutional LLC
DUNS: 790384502
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Rifampin
PRODUCT DETAILS
NDC Product Code67457-445
Application NumberANDA065421
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateDecember 8, 2018
Generic NameRifampin
INGREDIENTS (3)
RIFAMPINActive
Quantity: 600 mg in 10 mL
Code: VJT6J7R4TR
Classification: ACTIB
SODIUM FORMALDEHYDE SULFOXYLATEInactive
Code: X4ZGP7K714
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT